Vimarsana
Biggest News Aggregation in the World

Page 37 - Masimo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Masimo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Masimo Today - Breaking & Trending Today

Masimo takes bite at Apple Watch charger design - Vimarsana News

Masimo takes bite at Apple Watch charger design

PTAB denies med tech company’s validity challenge of Apple’s design patents | Latest ruling continues the legal battle between the two companies.

Masimo W1 Medical Watch Gets FDA Clearance for OTC and Prescription Use - Vimarsana News

Masimo W1 Medical Watch Gets FDA Clearance for OTC and Prescription Use

By Stephen Nakrosis Masimo on Friday said the Masimo W1 medical watch received 510(k) clearance from the U.S. Food and Drug Administration for...

Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use - Vimarsana News

Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use

Masimo today announced that the Masimo W1™ medical watch has received FDA 510 clearance for over-the-counter and prescription use . Masimo W1 is the first FDA-cleared watch to provide continuous...

Masimo (NASDAQ:MASI) Price Target Cut to $81.00 by Analysts at Wells Fargo & Company - Vimarsana News

Masimo (NASDAQ:MASI) Price Target Cut to $81.00 by Analysts at Wells Fargo & Company

Masimo (NASDAQ:MASI – Free Report) had its price objective cut by Wells Fargo & Company from $110.00 to $81.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have an equal weight rating on the medical equipment provider’s stock. A number of other equities research analysts have also issued reports on […]

Masimo (NASDAQ:MASI) Releases Q4 Earnings Guidance - Vimarsana News

Masimo (NASDAQ:MASI) Releases Q4 Earnings Guidance

Masimo (NASDAQ:MASI – Get Free Report) issued an update on its fourth quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.74-$0.94 for the period, compared to the consensus estimate of $1.34. The company issued revenue guidance of $526-$576 million, compared to the consensus revenue estimate of $613.18 million. […]